For the first time, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have collaborated to develop a UK-wide asthma guideline.
Talks with the makers of Enhertu have ended without agreement, meaning guidance that does not recommend Enhertu for advanced breast cancer will remain unchanged.
Draft guidance issued for consultation recommends two technologies to help people manage their condition.
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
How Clatterbridge Cancer Centre improved early detection rates of metatstatic spinal cord compression, and increased the average survival rates of patients through following our recommendations.
Colleagues in our Science Policy and Research Programme discuss their international research, paving the way for next generation health technology assessment.
5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.
